Similar articles

• Thrombotic obstruction of Bjork-Shiley tricuspid valve prosthesis. Report of three cases reoperated with success.

  Azpitarte J, De Vega NG, Santalla A, Rábago P, Rábago G. Azpitarte J, et al. Acta Cardiol. 1975;30(6):419-26. Acta Cardiol. 1975. PMID: 1084663
• Treatment of prosthetic tricuspid valve thrombosis with recombinant tissue-type plasminogen activator.

  Cambier P, Mombaerts P, De Geest H, Collen D, Van De Werf F. Cambier P, et al. Eur Heart J. 1987 Aug;8(8):906-9. doi: 10.1093/oxfordjournals.eurheartj.a062356. Eur Heart J. 1987. PMID: 3117553
• Tricuspid valve surgery.

  Schoevaerdts JC, Jaumin P, Piret L, Kremer R, Ponlot R, Chalant CH. Schoevaerdts JC, et al. J Cardiovasc Surg (Torino). 1977 Jul-Aug;18(4):397-9. J Cardiovasc Surg (Torino). 1977. PMID: 885902
• [Diagnosis and treatment of lesions of the tricuspid valve: an unresolved problem].

  Poveda JJ, Martín-Durán R, Revuelta JM. Poveda JJ, et al. Rev Esp Cardiol. 1990 May;43(5):328-40. Rev Esp Cardiol. 1990. PMID: 2203122 Review. Spanish. No abstract available.
• Evaluation and management of tricuspid valve disease.

  Kratz J. Kratz J. Cardiol Clin. 1991 May;9(2):397-407. Cardiol Clin. 1991. PMID: 2054825 Review.